ArticleJournal of translational medicine2023

ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.

Jinming Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.